Bone Loss Completed Phase 3 Trials for Letrozole (DB01006)
Also known as: Osteopenia / Osteopenia (disorder) / Osteopenia (morphologic abnormality) / Osteopaenia
| Indication | Status | Phase |
|---|---|---|
| DBCOND0031952 (Bone Loss) | Completed | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00171340 | Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. | Treatment |